SODIUM PYROVANADATE

Suppliers

Names

[ Name ]:
SODIUM PYROVANADATE

[Synonym ]:
sodiumparavanadate
Tetrasodium divanadinate
sodiumvanadiumoxide(na4v2o7)
MFCD01310449
EINECS 236-859-5
sodiumvanadate(v)(na4v2o7)
Tetrasodium Pyrovanadinate
SODIUM VANADATE (PYRO)
vanadate(v2o74-),tetrasodium
tetrasodium heptaoxodivanadate

Chemical & Physical Properties

[ Molecular Formula ]:
Na₄O₇V₂

[ Molecular Weight ]:
305.83800

[ Exact Mass ]:
305.81100

[ PSA ]:
135.61000

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :: WD7900000

CHEMICAL NAME :: Sodium pyrovanadate

CAS REGISTRY NUMBER :: 13517-26-5

LAST UPDATED :: 199701

DATA ITEMS CITED :: 24

MOLECULAR FORMULA :: O7-V2.4Na

MOLECULAR WEIGHT :: 305.84

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 67 mg/kg

TOXIC EFFECTS :: Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold

REFERENCE :: AJSNAO American Journal of Syphilis and Neurology. (St. Louis, MO) V.1-19, 1917-35. For publisher information, see AJSGA3. Volume(issue)/page/year: 1,347,1917

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 94 mg/kg

TOXIC EFFECTS :: Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold

REFERENCE :: AJSNAO American Journal of Syphilis and Neurology. (St. Louis, MO) V.1-19, 1917-35. For publisher information, see AJSGA3. Volume(issue)/page/year: 1,347,1917

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 5 mg/kg

TOXIC EFFECTS :: Lungs, Thorax, or Respiration - respiratory depression Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold

REFERENCE :: AJSNAO American Journal of Syphilis and Neurology. (St. Louis, MO) V.1-19, 1917-35. For publisher information, see AJSGA3. Volume(issue)/page/year: 1,347,1917

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - guinea pig

DOSE/DURATION :: 2 mg/kg

REFERENCE :: AJSNAO American Journal of Syphilis and Neurology. (St. Louis, MO) V.1-19, 1917-35. For publisher information, see AJSGA3. Volume(issue)/page/year: 1,347,1917 *** REVIEWS *** TOXICOLOGY REVIEW 85DHAX "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Volume(issue)/page/year: V,46,1974 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-AUSTRALIA:TWA 0.05 mg(V2O5)/m3 JAN 1993 OEL-BELGIUM:TWA 0.05 mg(V2O5)/m3 JAN 1993 OEL-DENMARK:TWA 0.03 mg(V2O5)/m3 JAN 1993 OEL-FINLAND:TWA 0.5 mg(V2O5)/m3 JAN 1993 OEL-FRANCE:TWA 0.05 mg(V2O5)/m3 JAN 1993 OEL-GERMANY:TWA 0.05 mg(V2O5)/m3 JAN 1993 OEL-HUNGARY:TWA 0.05 mg(V2O5)/m3;STEL 0.1 mg(V205)/m3 JAN 1993 OEL-JAPAN:TWA 0.5 mg(V2O5)/m3 JAN 1993 OEL-THE NETHERLANDS:TWA 0.5 mg(V2O5)/m3 JAN 1993 OEL-THE PHILIPPINES:TWA 0.25 mg(V205)/m3 JAN 1993 OEL-POLAND:TWA 0.5 mg(V2O5)/m3 JAN 1993 OEL-SWEDEN:STEL 0.05 mg(V2O5)/m3 JAN 1993 OEL-SWEDEN:TWA 0.2 mg(V2O5)/m3 (dust) JAN 1993 OEL-SWITZERLAND:TWA 0.05 mg(V2O5)/m3;STEL 0.25 mg(V2O5)/m3 JAN 1993 OEL-TURKEY:TWA 0.5 mg(V2O5)/m3 JAN 1993 OEL-UNITED KINGDOM:TWA 0.05 mg(V2O5)/m3 (dust) JAN 1993 OEL-UNITED KINGDOM:TWA 0.5 mg(V2O5)/m3 JAN 1993 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO VANADIUM (as V2O5), resp dust/fume-air:CL 0.05 mg/m3/15M REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992

Safety Information

[ RIDADR ]:
UN 3285 6.1/PG 3

[ WGK Germany ]:
3

[ RTECS ]:
WD7900000

Related Compounds

sodium,(Z)-4-[(2-amino-3-methylbutanoyl)amino]-3-chloro-5-hydroxy-5-oxopent-2-enoate
sodium lauroamphoacetate
α-Lactalbumin
sodium 2,8,8-trimethyl-3-oxo-1,7-diaza-4-oxabicyclo<3.2.1>octane-6-carboxylate
sodium [[[(heptadecafluorooctyl)sulphonyl]amino]methyl]benzenesulphonate
sodium 5-chloro-3-[(1,5-dihydroxy-2-naphthyl)azo]-2-hydroxybenzenesulphonate
3-(Piperidine-1-carbonyl)cyclopentanecarboxylic acid
5-(2-chloro-6-fluorophenyl)-3-(3,5-dimethoxyphenyl)-1-(methylsulfonyl)-4,5-dihydro-1H-pyrazole
5-amino-1-tosyl-1H-pyrazol-3-yl thiophene-3-carboxylate
furan-2-yl(5-(3-hydroxy-4-methoxyphenyl)-3-(thiophen-3-yl)-4,5-dihydro-1H-pyrazol-1-yl)methanone
1-(5-(3-hydroxy-4-methoxyphenyl)-3-(thiophen-3-yl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone
1-(5-(5-methylthiophen-2-yl)-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone
3-fluoro-N-[2-(3-oxo-3,4-dihydroquinoxalin-2-yl)phenyl]benzene-1-sulfonamide
N-(2-benzoyl-5-methylphenyl)-2-(piperidin-1-yl)acetamide
N-(2-benzoyl-5-chlorophenyl)-2-morpholinoacetamide
8-chloro-5-phenyl-4,5-dihydro-1H-benzo[e][1,4]diazepin-2(3H)-one

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.